Michael Lee Brooks - Dec 22, 2021 Form 4 Insider Report for Syneos Health, Inc. (SYNH)

Role
Chief Development Officer, Clinical Solutions
Signature
/s/ Sara Epstein, Attorney-in-Fact
Stock symbol
SYNH
Transactions as of
Dec 22, 2021
Transactions value $
-$9,207
Form type
4
Date filed
12/23/2021, 04:02 PM
Previous filing
Dec 20, 2021
Next filing
Jan 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYNH Class A Common Stock Sale -$9.21K -93 -1.04% $99.00 8.83K Dec 22, 2021 By spouse F1
holding SYNH Class A Common Stock 33K Dec 22, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on November 19, 2021.

Remarks:

Chief Development Officer, Clinical Solutions